These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 20307520)

  • 1. HDL in humans with cardiovascular disease exhibits a proteomic signature.
    Vaisar T; Mayer P; Nilsson E; Zhao XQ; Knopp R; Prazen BJ
    Clin Chim Acta; 2010 Jul; 411(13-14):972-9. PubMed ID: 20307520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isoforms of apolipoprotein C-I associated with individuals with coronary artery disease.
    Moore D; McNeal C; Macfarlane R
    Biochem Biophys Res Commun; 2011 Jan; 404(4):1034-8. PubMed ID: 21187063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined High-Density Lipoprotein Proteomic and Glycomic Profiles in Patients at Risk for Coronary Artery Disease.
    Krishnan S; Huang J; Lee H; Guerrero A; Berglund L; Anuurad E; Lebrilla CB; Zivkovic AM
    J Proteome Res; 2015 Dec; 14(12):5109-18. PubMed ID: 26535788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The HDL proteome: a marker--and perhaps mediator--of coronary artery disease.
    Heinecke JW
    J Lipid Res; 2009 Apr; 50 Suppl(Suppl):S167-71. PubMed ID: 19060251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of an HDL Apolipoproteomic Score With Coronary Atherosclerosis and Cardiovascular Death.
    Natarajan P; Collier TS; Jin Z; Lyass A; Li Y; Ibrahim NE; Mukai R; McCarthy CP; Massaro JM; D'Agostino RB; Gaggin HK; Bystrom C; Penn MS; Januzzi JL
    J Am Coll Cardiol; 2019 May; 73(17):2135-2145. PubMed ID: 31047001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasmalogens of high-density lipoproteins (HDL) are associated with coronary artery disease and anti-apoptotic activity of HDL.
    Sutter I; Velagapudi S; Othman A; Riwanto M; Manz J; Rohrer L; Rentsch K; Hornemann T; Landmesser U; von Eckardstein A
    Atherosclerosis; 2015 Aug; 241(2):539-46. PubMed ID: 26093887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and characterization of a rare variant in apolipoprotein A-IV, p.(V336M), and evaluation of HDL functionality in a Greek cohort with extreme HDL cholesterol levels.
    Chroni A; Rallidis L; Vassou D; Gkolfinopoulou C; Papakosta P; Zervou MI; Goulielmos GN; Kiouri E; Pappa D; Eliopoulos E; Kardassis D
    Arch Biochem Biophys; 2020 Dec; 696():108655. PubMed ID: 33130088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Shotgun proteomics implicates protease inhibition and complement activation in the antiinflammatory properties of HDL.
    Vaisar T; Pennathur S; Green PS; Gharib SA; Hoofnagle AN; Cheung MC; Byun J; Vuletic S; Kassim S; Singh P; Chea H; Knopp RH; Brunzell J; Geary R; Chait A; Zhao XQ; Elkon K; Marcovina S; Ridker P; Oram JF; Heinecke JW
    J Clin Invest; 2007 Mar; 117(3):746-56. PubMed ID: 17332893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mass Spectrometry-Based Proteomic Study Makes High-Density Lipoprotein a Biomarker for Atherosclerotic Vascular Disease.
    Chang CT; Yang CY; Tsai FJ; Lin SY; Chen CJ
    Biomed Res Int; 2015; 2015():164846. PubMed ID: 26090384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human apolipoprotein A-II determines plasma triglycerides by regulating lipoprotein lipase activity and high-density lipoprotein proteome.
    Julve J; Escolà-Gil JC; Rotllan N; Fiévet C; Vallez E; de la Torre C; Ribas V; Sloan JH; Blanco-Vaca F
    Arterioscler Thromb Vasc Biol; 2010 Feb; 30(2):232-8. PubMed ID: 19910634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HDL subpopulations containing apoA-I without apoA-II (LpA-I) in patients with angiographically proven coronary artery disease.
    Kuchta A; Strzelecki A; Ćwiklińska A; Gruchała M; Zdrojewski Z; Kortas-Stempak B; Wieczorek E; Gliwińska A; Dąbkowski K; Jankowski M
    J Cardiol; 2017 Mar; 69(3):523-528. PubMed ID: 27169356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of covalent modifications of HDL apoproteins by endogenous oxidized phospholipids.
    Gao D; Podrez EA
    Free Radic Biol Med; 2018 Feb; 115():57-67. PubMed ID: 29155052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased electronegativity of high-density lipoprotein in uremia patients impairs its functional properties and is associated with the risk of coronary artery disease.
    Chang CT; Shen MY; Hsieh JY; Chang CM; Liao HY; Chen FY; Hsu CY; Yang CY; Chen CJ
    Atherosclerosis; 2018 Nov; 278():147-155. PubMed ID: 30278357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An effective and rapid determination by MALDI/TOF/TOF of methionine sulphoxide content of ApoA-I in type 2 diabetic patients.
    Seraglia R; Sartore G; Marin R; Burlina S; Manzato E; Ragazzi E; Traldi P; Lapolla A
    J Mass Spectrom; 2013 Jan; 48(1):105-10. PubMed ID: 23303753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of specifically oxidized apolipoproteins in mildly oxidized high density lipoprotein.
    Pankhurst G; Wang XL; Wilcken DE; Baernthaler G; Panzenböck U; Raftery M; Stocker R
    J Lipid Res; 2003 Feb; 44(2):349-55. PubMed ID: 12576517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HDL proteome in hemodialysis patients: a quantitative nanoflow liquid chromatography-tandem mass spectrometry approach.
    Mangé A; Goux A; Badiou S; Patrier L; Canaud B; Maudelonde T; Cristol JP; Solassol J
    PLoS One; 2012; 7(3):e34107. PubMed ID: 22470525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ApoE and apoC-III-defined HDL subtypes: a descriptive study of their lecithin cholesterol acyl transferase and cholesteryl ester transfer protein content and activity.
    Amaya-Montoya M; Pinzón-Cortés JA; Silva-Bermúdez LS; Ruiz-Manco D; Pérez-Matos MC; Jiménez-Mora MA; Mendivil CO
    Lipids Health Dis; 2020 May; 19(1):106. PubMed ID: 32450892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening and identification of potential biomarkers and establishment of the diagnostic serum proteomic model for the Traditional Chinese Medicine Syndromes of tuberculosis.
    Liu J; Li Y; Wei L; Yang X; Xie Z; Jiang T; Wang C; Zhang X; Xu D; Chen Z; Yang F; Li JC
    J Ethnopharmacol; 2014 Sep; 155(2):1322-31. PubMed ID: 25072359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apolipoprotein C-III in the high-density lipoprotein proteome of cerebral lacunar infarction patients impairs its anti-inflammatory function.
    Lv P; Zhao M; Liu Y; Jin H; Cui W; Fan C; Teng Y; Zheng L; Huang Y
    Int J Mol Med; 2018 Jan; 41(1):61-68. PubMed ID: 29115584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-density lipoprotein oxidation in type 2 diabetic patients and young patients with premature myocardial infarction.
    Sartore G; Seraglia R; Burlina S; Bolis A; Marin R; Manzato E; Ragazzi E; Traldi P; Lapolla A
    Nutr Metab Cardiovasc Dis; 2015 Apr; 25(4):418-25. PubMed ID: 25636381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.